Sara Jacobs sold Quest Diagnostics Incorporated (NYSE: DGX)
Sara Jacobs (D-CA), a U.S. Representative, has disclosed 1 trade in Quest Diagnostics Incorporated (DGX) since 2021, a single sale, worth an estimated $75K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Sara Jacobs sold $50,001 - $100,000 of Quest Diagnostics Incorporated (NYSE: DGX) on April 9, 2021. Since that trade, DGX is up +105.72% against the S&P 500 up +89.81%, an outperformance of +15.91%.
Data updated
Sara Jacobs's DGX trades vs the price
DGX is up +105.72% since Sara Jacobs sold on April 9, 2021, versus +89.81% for the S&P 500.
Performance since this trade
All Sara Jacobs DGX trades
Sara Jacobs & DGX trading FAQ
Is it legal for Sara Jacobs to trade Quest Diagnostics Incorporated (DGX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Quest Diagnostics Incorporated (DGX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Sara Jacobs sell DGX?
Sara Jacobs disclosed a sale of $50,001 - $100,000 of Quest Diagnostics Incorporated (DGX) on April 9, 2021, according to public STOCK Act filings.
How has DGX performed since Sara Jacobs's trade?
Since Sara Jacobs sold DGX on April 9, 2021, the stock is up +105.72%, versus +89.81% for the S&P 500 over the same period, an outperformance of +15.91%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional DGX trades?
Quantellect tracks every disclosed congressional trade in Quest Diagnostics Incorporated (DGX) on the Quest Diagnostics Incorporated congressional trading page, which aggregates filings across all members of Congress.
Sara Jacobs's DGX tradesAll congressional filings for Quest Diagnostics IncorporatedSara Jacobs's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.